Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Obesity - independent risk factor for cardiomyopathy? (CROSBI ID 601768)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | domaća recenzija

Selthofer-Relatić , Kristina Obesity - independent risk factor for cardiomyopathy? // Cardiologia Croatica. 2012

Podaci o odgovornosti

Selthofer-Relatić , Kristina

engleski

Obesity - independent risk factor for cardiomyopathy?

According to World Health Organisation obesity is global epidemic problem, with serious health complications and consequences like psyhosocial stress, physical morbidity, premature death. Obesity is chronic disorder and risk factor for conventional cardiometabolic risk factors, but is it independent risk factor for cardiac hypertrophy and cardiomyopathy? Adipose tissue acting as active endocrine organ with possibility of synthesis of many bioactive molecules, such as proinflammatory interleukins, cytokines, chemokines and adipokines. Concentrations of many adipokines are changing with the body mass index and body fat distribution, where visceral adipose tisue plays a more determinant role in defining related disease risk than subcutaneous adipose tissue. According to latest research, obesity is related to dyslipidemia, diabetes mellitus, hypertension, ishaemic heart disease, heart failure, chronic kidney disease and anxiodepresive disorders. Adipokines, product of adipose tissue, induce changes of related tissue and organs trought the process of inflammation, vasoconstriction, insulin resistance, oxidative stress, endothelial dysfunction and increased concentrations of free fatty acids. It can be concluded that obesity affect the cardiomyopathy development trough haemodynamic factors that cause left ventricular hypertrophy and trough non-hemodynamic, neurohumoral factors such as adipocytokine dysregulation and inflammation affecting cardiomyocytes and myocardium by depositing triglycerides and free fatty acids, myocardium matrix remodelling, trough activation of hypertrophic and profibrotic signals.

cardiomyopathy; obesity

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2012.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Cardiologia Croatica

1848-5448

Podaci o skupu

9. kongres Hrvatskog kardiološkog društva

predavanje

13.10.2012-16.10.2012

Opatija, Hrvatska

Povezanost rada

Kliničke medicinske znanosti